On Nov. 10, Eli Lilly, one of three pharmaceutical companies that collectively dominate the global insulin market, tweeted out, “we are excited to announce that insulin is free now.” With the adorned blue check, normally an indicator of a verified celebrity or corporate twitter account, the announcement went semi-viral. Eli Lilly’s stock price tumbled and many online laughed at how Twitter seemed to be imploding after a few short weeks with Elon Musk at the helm. But when one looks just slightly past the weeds of trolls and memes, contradictions inherent to capitalism smack you straight in the face.